Latest Breaking News On - Bramerton holdings - Page 1 : comparemela.com
IIT Kharagpur launches COVIRAP diagnostic technology
yourstory.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yourstory.com Daily Mail and Mail on Sunday newspapers.
IIT-Kharagpur Aims To Commercialise COVIRAP That Can Detect Coronavirus In 45 Minutes
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
21 April 2021 | News Licensed for commercialisation to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA
IIT Kharagpur (Kgp) has successfully commercialized its flagship healthcare product – COVIRAP – the novel diagnostic technology for infectious diseases including COVID-19 and beyond.
The product developed by lead researchers Professor Suman Chakraborty, Dr. Arindam Mondal and their research group has been licensed for commercialization to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
Bramerton Holdings has signed a record deal for securing global rights for commercially disseminating the COVIRAP technology developed at IIT Kharagpur in various geographical locations outside the territory of the Indian subcontinent. Rapid Diagnostic has also initiated adapting the COVIRAP technology plat
Coronavirus | IIT Kharagpur launches COVIRAP diagnostic technology
Updated:
Updated:
The results can be made available within 45 minutes of obtaining the patient sample.
Share Article
AAA
For use of the test, the nasal, as well as oral swab samples, are diluted in a solution and tested in the portable device. | Photo Credit:
Special Arrangement
The results can be made available within 45 minutes of obtaining the patient sample. IIT Kharagpur has successfully commercialised its flagship healthcare product COVIRAP the novel diagnostic technology to zero on infectious diseases including COVID-19, the institute said Wednesday.
The product, developed by lead researchers Professor Suman Chakraborty, Dr Arindam Mondal and their research group, has been licensed for commercialisation to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
21 April 2021 | News Licensed for commercialisation to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA
IIT Kharagpur (Kgp) has successfully commercialized its flagship healthcare product – COVIRAP – the novel diagnostic technology for infectious diseases including COVID-19 and beyond.
The product developed by lead researchers Professor Suman Chakraborty, Dr. Arindam Mondal and their research group has been licensed for commercialization to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
Bramerton Holdings has signed a record deal for securing global rights for commercially disseminating the COVIRAP technology developed at IIT Kharagpur in various geographical locations outside the territory of the Indian subcontinent. Rapid Diagnostic has also initiated adapting the COVIRAP technology plat
vimarsana © 2020. All Rights Reserved.